2025-04-13 13:38:54
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Zenotech Laboratories Ltd Q4FY21 PAT rises to Rs. 1.17 crore
Posted On : 2021-05-01 15:50:44( TIMEZONE : IST )
ZENOTECH LABORATORIES LTD. has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.8.19 crores during the period ended March 31, 2021 as compared to Rs.5.67 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.17 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.0.07 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.19 for the period ended March 31, 2021 as compared to Rs.0.01 for the period ended December 31, 2020.
| Financials | Q4 FY20-21 | Q3 FY20-21 | % Change |
| Total Income | ₹ 8.19 crs | ₹ 5.67 crs |  44.44% |
| Net Profit | ₹ 1.17 crs | ₹ 0.07 crs | 1571.43% |
| EPS | ₹ 0.19 | ₹ 0.01 | 1800% |
Financial Results (Q4 FY20-21) - YoY Comparison
The company has reported total income of Rs.8.19 crores during the period ended March 31, 2021 as compared to Rs.5.54 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.1.17 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.(0.03) crores for the period ended March 31, 2020.
The company has reported EPS of Rs.0.19 for the period ended March 31, 2021 as compared to Rs.(0.01) for the period ended March 31, 2020.
| Financials | Q4 FY20-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 8.19 crs | ₹ 5.54 crs | 47.83% |
| Net Profit | ₹ 1.17 crs | ₹ (0.03) crs | 4000% |
| EPS | ₹ 0.19 | ₹ (0.01) | -2000% |
Financial Results (Year ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.22.85 crores during the 12 months period ended March 31, 2021 as compared to Rs.27.19 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.(1.21) crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.10.77 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.(0.20) for the 12 months period ended March 31, 2021 as compared to Rs.1.77 for the 12 months period ended March 31, 2020.
| Financials | Year Ended FY20-21 | Year Ended FY19-20 | % Change |
| Total Income | ₹ 22.85 crs | ₹ 27.19 crs |  -15.96% |
| Net Profit | ₹ (1.21) crs | ₹ 10.77 crs | -111.23% |
| EPS | ₹ (0.20) | ₹1.77 | -111.3% |
Shares of ZENOTECH LABORATORIES LTD. was last trading in BSE at Rs.43.4 as compared to the previous close of Rs. 42.4. The total number of shares traded during the day was 14434 in over 119 trades.
The stock hit an intraday high of Rs. 43.45 and intraday low of 40.75. The net turnover during the day was Rs. 618693.
